New Government-Funded Study Finds Cannabis May Treat Fragile X Syndrome

A new study published by the journal Behavioral Brain Research has found that cannabis may treat Fragile X syndrome, also known as Martin-Bell syndrome,brightleaf which is a “genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment”, according to the National Institute of Health which conducted and funded the study.

“Silencing the gene FMR1 in fragile X syndrome (FXS) with consequent loss of its protein product, FMRP, results in intellectual disability, hyperactivity, anxiety, seizure disorders, and autism-like behavior”, claims researchers. “In a mouse model of FXS, a deficit in performance on the passive avoidance test of learning and memory is a robust phenotype. We report that drugs acting on the endocannabinoid (eCB) system [such as cannabis] can improve performance on this test.”

Read moreNew Government-Funded Study Finds Cannabis May Treat Fragile X Syndrome